![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Leo Pharma A/s Ballerup Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Sodium fusidate, Micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-317 - Rev 02
This Chemical Type CEP, issued on January 19, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 848 associated with this CEP further emphasizes